استفاده از پلاسمای خون در تسریع روند بهبود ورزشکاران پس از جراحی
الموضوعات :
دانیال تارمست
1
,
اردشیر ظفری
2
1 - دانشگاه آزاد اسلامی واحد پرند
2 - استادیار فیزیولوژی ورزش، گروه علوم ورزشی، دانشکده علوم انسانی و هنر، واحد زنجان، دانشگاه آزاد اسلامی، زنجان، ایران.
الکلمات المفتاحية: پلاسما, پلاکت, PRP, بازسازی بافت, تسریع بهبود در ورزشکاران, آسیب دیدگی ورزشی, جراحی,
ملخص المقالة :
پلاسمای غنی از پلاکت (Platelet-rich plasma-PRP) به عنوان یک روش نوین در پزشکی بازساختی، به ویژه در بهبود بافت‌های آسیب‌دیده در ورزشکاران، مورد توجه بسیاری از محققان و متخصصان قرار گرفته است. در این روش بالینی، که از خون خود بیمار استفاده می‌شود، و حاوی تراکم بالایی از پلاکت‌ها و فاکتورهای رشد است، می‌تواند فرآیندهای ترمیمی را در بافت‌های مختلف تحریک کرده و بهبود زخم‌ها و آسیب‌های ناشی از جراحی را تسریع کند. در روش تهیه PRP به دلیل ویژگی‌های کم‌تهاجمی و ایمنی بالا، به سرعت در میان ورزشکاران حرفه‌ای و آماتور محبوبیت یافته است. در دنیای ورزش حرفه‌ای، آسیب‌های فیزیکی ناشی از تمرینات و رقابت‌های شدید به‌طور مکرر رخ می‌دهد، و استفاده از PRP به عنوان یک ابزار کمکی در جراحی‌های بازسازی‌کننده، نقش مهمی در تسریع بهبود و بازگشت ورزشکاران به میادین ورزشی ایفا کرده است. مقاله حاضر به بررسی کاربردهای مختلف PRP در درمان آسیب‌های رایج ورزشی، نظیر تاندونوپاتی، پارگی رباط‌ها، و آسیب‌های عضلانی و استخوانی می‌پردازد. برای مثال، PRP در درمان تاندونوپاتی آشیل که در میان دوندگان و فوتبالیست‌ها شایع است، نشان داده که می‌تواند فرآیند ترمیم تاندون را تسریع کرده، و زمان بازگشت به تمرینات و مسابقات را کاهش دهد. همچنین، در جراحی‌های بازسازی رباط صلیبی قدامی به عنوان یک درمان مکمل، PRP به بهبود سریع‌تر و کاهش التهاب پس از عمل کمک کرده و بازگشت سریع ورزشکاران به فعالیت‌های ورزشی را تسهیل می‌کند. علاوه بر این، PRP در درمان آسیب‌های عضلانی نظیر پارگی عضلات همسترینگ، که در میان دوندگان و بازیکنان فوتبال رایج است، مؤثر بوده و با تحریک فرآیندهای بازسازی سلولی، زمان بهبود را کاهش داده و خطر عود مجدد آسیب را کم کرده است. همچنین، در درمان شکستگی که در ورزشکاران دو استقامت و ورزش‌های برخوردی شایع است، با تسریع جوش‌خوردگی استخوان، و بازگشت به تمرینات را امکان‌پذیر کرده است.
المصادر:
1. Mishra A, Harmon K, Woodall J, Vieira A. Sports medicine applications of platelet rich plasma. Curr Pharm Biotechnol. 2012;13(7):1185-95. Epub 2011/07/12. doi: 10.2174/138920112800624283. PubMed PMID: 21740373.
2. Tarmast D. The Critical Role of Nutrition in Acceleration of the Rehabilitation Process in Athletes. Journal of Physiology of Training and Sports Injuries. 2024;2(1):29-39.
3. Raum G, Kenyon C, Bowers R. Platelet-Poor versus Platelet-Rich Plasma for the Treatment of Muscle Injuries. Curr Sports Med Rep. 2024;23(6):222-8. Epub 2024/06/06. doi: 10.1249/JSR.0000000000001173. PubMed PMID: 38838685.
4. Sourugeon Y, Yonai Y, Berkovich Y, Laver L. Platelet-Rich Plasma Treatment for Muscle Injuries. Musculoskeletal Injections Manual: Basics, Techniques and Injectable Agents. 2024:99-104. doi: 10.1007/978-3-031-52603-9_17.
5. Paichitrojjana A, Paichitrojjana A. Platelet rich plasma and its use in hair regrowth: a review. Drug Design, Development and Therapy. 2023:635-45. doi: 10.2147/DDDT.S356858. PubMed Central PMCID: PMC35300222.
6. Zaki SN, Mardyansyah, Oktarina C, Purwoko RY, Sutanto HU. Platelet-Rich Plasma for the Treatment of Atopic Dermatitis: A Literature Review. J Clin Aesthet Dermatol. 2024;17(7):43-9. Epub 2024/07/15. PubMed PMID: 39006806; PubMed Central PMCID: PMCPMC11238712.
7. Xu J, Gou L, Zhang P, Li H, Qiu S. Platelet-rich plasma and regenerative dentistry. Aust Dent J. 2020;65(2):131-42. Epub 2020/03/08. doi: 10.1111/adj.12754. PubMed PMID: 32145082; PubMed Central PMCID: PMCPMC7384010.
8. Kon E, Filardo G, Di Martino A, Marcacci M. Platelet-rich plasma (PRP) to treat sports injuries: evidence to support its use. Knee Surg Sports Traumatol Arthrosc. 2011;19(4):516-27. Epub 2010/11/18. doi: 10.1007/s00167-010-1306-y. PubMed PMID: 21082164.
9. Marques LF, Stessuk T, Camargo IC, Sabeh Junior N, dos Santos L, Ribeiro-Paes JT. Platelet-rich plasma (PRP): methodological aspects and clinical applications. Platelets. 2015;26(2):101-13. Epub 2014/02/12. doi: 10.3109/09537104.2014.881991. PubMed PMID: 24512369.
10. Tarmast D, Ghosh AK. The Impact of Carbohydrate, Protein, and Combined Carbohydrate-Protein Supplementation on Muscle Damage and Oxidative Stress Markers During Prolonged Cycling Performance in the Heat. Asian Journal of Sports Medicine. 2024;15(2):e144084. Epub 2024-08-01. doi: 10.5812/asjsm-144084.
11. Zhu T, Zhou J, Hwang J, Xu X. Effects of Platelet-Rich Plasma on Clinical Outcomes After Anterior Cruciate Ligament Reconstruction: A Systematic Review and Meta-analysis. Orthop J Sports Med. 2022;10(1):23259671211061535. Epub 2022/02/08. doi: 10.1177/23259671211061535. PubMed PMID: 35127959; PubMed Central PMCID: PMCPMC8811441.
12. Flury M, Rickenbacher D, Schwyzer H-K, Jung C, Schneider MM, Stahnke K, et al. Does pure platelet-rich plasma affect postoperative clinical outcomes after arthroscopic rotator cuff repair? A randomized controlled trial. The American journal of sports medicine. 2016;44(8):2136-46. doi: 10.1177/0363546516645518. PubMed Central PMCID: PMC27184542.
13. Manso BA, Rodriguez YBA, Forsberg EC. From Hematopoietic Stem Cells to Platelets: Unifying Differentiation Pathways Identified by Lineage Tracing Mouse Models. Cells. 2024;13(8):704. Epub 2024/04/26. doi: 10.3390/cells13080704. PubMed PMID: 38667319; PubMed Central PMCID: PMCPMC11048769.
14. Malara A, Abbonante V, Zingariello M, Migliaccio A, Balduini A. Megakaryocyte Contribution to Bone Marrow Fibrosis: many Arrows in the Quiver. Mediterr J Hematol Infect Dis. 2018;10(1):e2018068. Epub 2018/11/13. doi: 10.4084/MJHID.2018.068. PubMed PMID: 30416700; PubMed Central PMCID: PMCPMC6223581.
15. Psaila B, Lyden D, Roberts I. Megakaryocytes, malignancy and bone marrow vascular niches. J Thromb Haemost. 2012;10(2):177-88. Epub 2011/11/30. doi: 10.1111/j.1538-7836.2011.04571.x. PubMed PMID: 22122829; PubMed Central PMCID: PMCPMC3272087.
16. Bates DO, Beazley-Long N, Benest AV, Ye X, Ved N, Hulse RP, et al. Physiological role of vascular endothelial growth factors as homeostatic regulators. Comprehensive Physiology. 2018;8(3). doi: 10.1002/cphy.c170015. PubMed Central PMCID: PMC29978898.
17. Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M. Growth factors and cytokines in wound healing. Wound Repair Regen. 2008;16(5):585-601. Epub 2009/01/09. doi: 10.1111/j.1524-475X.2008.00410.x. PubMed PMID: 19128254.
18. Wee P, Wang Z. Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways. Cancers (Basel). 2017;9(5):52. Epub 2017/05/18. doi: 10.3390/cancers9050052. PubMed PMID: 28513565; PubMed Central PMCID: PMCPMC5447962.
19. Farooq M, Khan AW, Kim MS, Choi S. The Role of Fibroblast Growth Factor (FGF) Signaling in Tissue Repair and Regeneration. Cells. 2021;10(11):3242. Epub 2021/11/28. doi: 10.3390/cells10113242. PubMed PMID: 34831463; PubMed Central PMCID: PMCPMC8622657.
20. Creaney L, Hamilton B. Growth factor delivery methods in the management of sports injuries: the state of play. Br J Sports Med. 2008;42(5):314-20. Epub 2007/11/07. doi: 10.1136/bjsm.2007.040071. PubMed PMID: 17984193.
21. Andia I, Martin JI, Maffulli N. Advances with platelet rich plasma therapies for tendon regeneration. Expert Opin Biol Ther. 2018;18(4):389-98. Epub 2018/01/05. doi: 10.1080/14712598.2018.1424626. PubMed PMID: 29300106.
22. Andia I, Maffulli N. Muscle and tendon injuries: the role of biological interventions to promote and assist healing and recovery. Arthroscopy. 2015;31(5):999-1015. Epub 2015/01/27. doi: 10.1016/j.arthro.2014.11.024. PubMed PMID: 25618490.
23. Maffulli N, Longo UG, Kadakia A, Spiezia F. Achilles tendinopathy. Foot and Ankle Surgery. 2020;26(3):240-9. doi: 10.1016/j.fas.2019.03.009. PubMed Central PMCID: PMC31031150.
24. Patil P, Jadhav M, Suvvari TK, Thomas V. Therapeutic uses of platelet-rich plasma (PRP) in sport injuries–A narrative review. Journal of Orthopaedic Reports. 2023:100287. doi: 10.1016/j.jorep.2023.100287.
25. Yuan T, Zhang CQ, Wang JH. Augmenting tendon and ligament repair with platelet-rich plasma (PRP). Muscles Ligaments Tendons J. 2013;3(3):139-49. Epub 2013/12/25. PubMed PMID: 24367773; PubMed Central PMCID: PMCPMC3838322.
26. Laver L, Solis GS, Gilat R, García-Balletbó M, Lopez-Vidriero E, Cole B, et al. The Role of Orthobiologics for the Management of Ligament and Muscle Injuries in Sports. In: Laver L, Kocaoglu B, Cole B, Arundale AJH, Bytomski J, Amendola A, editors. Basketball Sports Medicine and Science. Berlin, Heidelberg: Springer Berlin Heidelberg; 2020. p. 587-603.
27. Barastegui D, Alentorn-Geli E, Gotecha D, Rius M, Navarro J, Cusco X, et al. Treatment of Partial Posterior Cruciate Ligament Injuries with Platelet-Rich Plasma in Growth Factors (PRGF) Intraligamentous Infiltration and a Specific Knee Brace. Surg J (N Y). 2021;7(1):e30-e4. Epub 2021/03/05. doi: 10.1055/s-0040-1722342. PubMed PMID: 33659640; PubMed Central PMCID: PMCPMC7917000.
28. Jordan M, Spörri J, Taylor J. Injury Prevention and Rehabilitation. In: Pritchard J, Taylor J, editors. The Science of Alpine Ski Racing: Routledge; 2022. p. 113-53.
29. Heiderscheit BC, Sherry MA, Silder A, Chumanov ES, Thelen DG. Hamstring strain injuries: recommendations for diagnosis, rehabilitation, and injury prevention. J Orthop Sports Phys Ther. 2010;40(2):67-81. Epub 2010/02/02. doi: 10.2519/jospt.2010.3047. PubMed PMID: 20118524; PubMed Central PMCID: PMCPMC2867336.
30. Herdea A, Struta A, Derihaci RP, Ulici A, Costache A, Furtunescu F, et al. Efficiency of platelet-rich plasma therapy for healing sports injuries in young athletes. Exp Ther Med. 2022;23(3):215. Epub 2022/02/08. doi: 10.3892/etm.2022.11139. PubMed PMID: 35126718; PubMed Central PMCID: PMCPMC8796279.
31. Nguyen RT, Borg-Stein J, McInnis K. Applications of platelet-rich plasma in musculoskeletal and sports medicine: an evidence-based approach. PM R. 2011;3(3):226-50. Epub 2011/03/16. doi: 10.1016/j.pmrj.2010.11.007. PubMed PMID: 21402369.
32. Weibrich G, Kleis WK, Hafner G. Growth factor levels in the platelet-rich plasma produced by 2 different methods: curasan-type PRP kit versus PCCS PRP system. Int J Oral Maxillofac Implants. 2002;17(2):184-90. Epub 2002/04/18. PubMed PMID: 11958400; PubMed Central PMCID: PMC11958400.
33. Marx RE. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg. 2004;62(4):489-96. Epub 2004/04/16. doi: 10.1016/j.joms.2003.12.003. PubMed PMID: 15085519.
34. Bava ED, Barber FA. Platelet-rich plasma products in sports medicine. Phys Sportsmed. 2011;39(3):94-9. Epub 2011/10/28. doi: 10.3810/psm.2011.09.1925. PubMed PMID: 22030945.
35. Yu H, Habibi M, Motamedi K, Semirumi DT, Ghorbani A. Utilizing stem cells in reconstructive treatments for sports injuries: An innovative approach. Tissue Cell. 2023;83:102152. Epub 2023/07/15. doi: 10.1016/j.tice.2023.102152. PubMed PMID: 37451009.
36. Boivin J, Tolsma R, Awad P, Kenter K, Li Y. The Biological Use of Platelet-Rich Plasma in Skeletal Muscle Injury and Repair. Am J Sports Med. 2023;51(5):1347-55. Epub 2021/12/15. doi: 10.1177/03635465211061606. PubMed PMID: 34904902.
37. Andia I, Sanchez M, Maffulli N. Tendon healing and platelet-rich plasma therapies. Expert Opin Biol Ther. 2010;10(10):1415-26. Epub 2010/08/20. doi: 10.1517/14712598.2010.514603. PubMed PMID: 20718690.
38. Padilla S, Sánchez M, Vaquerizo V, Malanga GA, Fiz N, Azofra J, et al. Platelet-rich plasma applications for Achilles tendon repair: a bridge between biology and surgery. International journal of molecular sciences. 2021;22(2):824. doi: 10.3390/ijms22020824. PubMed Central PMCID: PMC33467646.
39. Le ADK, Enweze L, DeBaun MR, Dragoo JL. Current Clinical Recommendations for Use of Platelet-Rich Plasma. Curr Rev Musculoskelet Med. 2018;11(4):624-34. Epub 2018/10/26. doi: 10.1007/s12178-018-9527-7. PubMed PMID: 30353479; PubMed Central PMCID: PMCPMC6220007.
40. Laver L, Carmont MR, McConkey MO, Palmanovich E, Yaacobi E, Mann G, et al. Plasma rich in growth factors (PRGF) as a treatment for high ankle sprain in elite athletes: a randomized control trial. Knee Surgery, Sports Traumatology, Arthroscopy. 2015;23:3383-92. doi: 10.1007/s00167-014-3119-x. PubMed Central PMCID: PMC24938396.
41. Cavallo C, Roffi A, Grigolo B, Mariani E, Pratelli L, Merli G, et al. Platelet-Rich Plasma: The Choice of Activation Method Affects the Release of Bioactive Molecules. Biomed Res Int. 2016;2016(1):6591717. Epub 2016/09/28. doi: 10.1155/2016/6591717. PubMed PMID: 27672658; PubMed Central PMCID: PMCPMC5031826.
42. Patel H, Pundkar A, Shrivastava S, Chandanwale R, Jaiswal AM. A Comprehensive Review on Platelet-Rich Plasma Activation: A Key Player in Accelerating Skin Wound Healing. Cureus. 2023;15(11):e48943. Epub 2023/12/18. doi: 10.7759/cureus.48943. PubMed PMID: 38106716; PubMed Central PMCID: PMCPMC10725573.
43. Asker M, Whiteley R. Rehabilitation and Return to Sports After Shoulder Injuries. Orthopaedic Sports Medicine: An Encyclopedic Review of Diagnosis, Prevention, and Management: Springer; 2024. p. 1-23.
44. Murrell WD, Tulpule S, Yurdi NA, Ezekwesili A, Maffulli N, Malanga GA. Orthobiologics for the Treatment of Tennis Elbow. Orthobiologics: Injectable Therapies for the Musculoskeletal System. 2022:191-204. doi: 10.1007/978-3-030-84744-9_15.
45. Wong JRY, Toth E, Rajesparan K, Rashid A. The use of platelet-rich plasma therapy in treating tennis elbow: A critical review of randomised control trials. J Clin Orthop Trauma. 2022;32:101965. Epub 2022/08/23. doi: 10.1016/j.jcot.2022.101965. PubMed PMID: 35990997; PubMed Central PMCID: PMCPMC9382321.
46. Miller TL, Kaeding CC, Rodeo SA. Emerging Options for Biologic Enhancement of Stress Fracture Healing in Athletes. J Am Acad Orthop Surg. 2020;28(1):1-9. Epub 2019/07/25. doi: 10.5435/JAAOS-D-19-00112. PubMed PMID: 31335452.
47. Sanders TL, Maradit Kremers H, Bryan AJ, Larson DR, Dahm DL, Levy BA, et al. Incidence of Anterior Cruciate Ligament Tears and Reconstruction: A 21-Year Population-Based Study. Am J Sports Med. 2016;44(6):1502-7. Epub 2016/02/28. doi: 10.1177/0363546516629944. PubMed PMID: 26920430.
48. Nessler T, Denney L, Sampley J. ACL injury prevention: what does research tell us? Current reviews in musculoskeletal medicine. 2017;10:281-8. doi: 10.1007/s12178-017-9416-5. PubMed Central PMCID: PMC28656531.
49. Thomas AC, Villwock M, Wojtys EM, Palmieri-Smith RM. Lower extremity muscle strength after anterior cruciate ligament injury and reconstruction. Journal of athletic training. 2013;48(5):610-20. doi: 10.4085/1062-6050-48.3.23. PubMed Central PMCID: PMC24067150.
50. Fleming BC, Spindler KP, Palmer MP, Magarian EM, Murray MM. Collagen-platelet composites improve the biomechanical properties of healing anterior cruciate ligament grafts in a porcine model. Am J Sports Med. 2009;37(8):1554-63. Epub 2009/04/02. doi: 10.1177/0363546509332257. PubMed PMID: 19336614; PubMed Central PMCID: PMCPMC2796133.
51. Radice F, Yánez R, Gutiérrez V, Rosales J, Pinedo M, Coda S. Comparison of magnetic resonance imaging findings in anterior cruciate ligament grafts with and without autologous platelet-derived growth factors. Arthroscopy: The Journal of Arthroscopic & Related Surgery. 2010;26(1):50-7. doi: 10.1016/j.arthro.2009.06.030. PubMed Central PMCID: PMC20117627.
52. López-Vidriero E, Olivé-Vilas R, López-Capapé D, Varela-Sende L, López-Vidriero R, Til-Pérez L. Efficacy and tolerability of progen, a nutritional supplement based on innovative plasma proteins, in ACL reconstruction: A multicenter randomized controlled trial. Orthopaedic Journal of Sports Medicine. 2019;7(2):2325967119827237. doi: 10.1177/2325967119827237. PubMed Central PMCID: PMC30834280.
53. Cervellin M, de Girolamo L, Bait C, Denti M, Volpi P. Autologous platelet-rich plasma gel to reduce donor-site morbidity after patellar tendon graft harvesting for anterior cruciate ligament reconstruction: a randomized, controlled clinical study. Knee Surg Sports Traumatol Arthrosc. 2012;20(1):114-20. Epub 2011/06/17. doi: 10.1007/s00167-011-1570-5. PubMed PMID: 21678095.
54. Rupreht M, Jevtic V, Sersa I, Vogrin M, Jevsek M. Evaluation of the tibial tunnel after intraoperatively administered platelet-rich plasma gel during anterior cruciate ligament reconstruction using diffusion weighted and dynamic contrast-enhanced MRI. J Magn Reson Imaging. 2013;37(4):928-35. Epub 2012/10/26. doi: 10.1002/jmri.23886. PubMed PMID: 23097413.
55. Vogrin M, Rupreht M, Dinevski D, Haspl M, Kuhta M, Jevsek M, et al. Effects of a platelet gel on early graft revascularization after anterior cruciate ligament reconstruction: a prospective, randomized, double-blind, clinical trial. Eur Surg Res. 2010;45(2):77-85. Epub 2010/09/04. doi: 10.1159/000318597. PubMed PMID: 20814217.
56. Seijas R, Ares O, Catala J, Alvarez-Diaz P, Cusco X, Cugat R. Magnetic resonance imaging evaluation of patellar tendon graft remodelling after anterior cruciate ligament reconstruction with or without platelet-rich plasma. Journal of Orthopaedic Surgery. 2013;21(1):10-4. doi: 10.1177/230949901302100105. PubMed Central PMCID: PMC23629979.
57. Chen W, Cloosterman KLA, Bierma-Zeinstra SMA, van Middelkoop M, de Vos RJ. Epidemiology of insertional and midportion Achilles tendinopathy in runners: A prospective cohort study. J Sport Health Sci. 2024;13(2):256-63. Epub 2023/03/25. doi: 10.1016/j.jshs.2023.03.007. PubMed PMID: 36963760; PubMed Central PMCID: PMCPMC10980873.
58. Fares MY, Khachfe HH, Salhab HA, Zbib J, Fares Y, Fares J. Achilles tendinopathy: Exploring injury characteristics and current treatment modalities. Foot (Edinb). 2021;46:101715. Epub 2020/10/12. doi: 10.1016/j.foot.2020.101715. PubMed PMID: 33039245.
59. Arthur Vithran DT, Xie W, Opoku M, Essien AE, He M, Li Y. The Efficacy of Platelet-Rich Plasma Injection Therapy in the Treatment of Patients with Achilles Tendinopathy: A Systematic Review and Meta-Analysis. J Clin Med. 2023;12(3):995. Epub 2023/02/12. doi: 10.3390/jcm12030995. PubMed PMID: 36769643; PubMed Central PMCID: PMCPMC9918262.
60. Weller CD, Gardiner EE, Arthur JF, Southey M, Andrews RK. Autologous platelet-rich plasma for healing chronic venous leg ulcers: Clinical efficacy and potential mechanisms. Int Wound J. 2019;16(3):788-92. Epub 2019/03/14. doi: 10.1111/iwj.13098. PubMed PMID: 30864220; PubMed Central PMCID: PMCPMC7949463.
61. Gentile P, Calabrese C, De Angelis B, Dionisi L, Pizzicannella J, Kothari A, et al. Impact of the Different Preparation Methods to Obtain Autologous Non-Activated Platelet-Rich Plasma (A-PRP) and Activated Platelet-Rich Plasma (AA-PRP) in Plastic Surgery: Wound Healing and Hair Regrowth Evaluation. Int J Mol Sci. 2020;21(2):431. Epub 2020/01/16. doi: 10.3390/ijms21020431. PubMed PMID: 31936605; PubMed Central PMCID: PMCPMC7014364.
62. Uzun H, Bitik O, Uzun O, Ersoy US, Aktas E. Platelet-rich plasma versus corticosteroid injections for carpal tunnel syndrome. J Plast Surg Hand Surg. 2017;51(5):301-5. Epub 2016/12/07. doi: 10.1080/2000656X.2016.1260025. PubMed PMID: 27921443.
63. Wu YT, Ho TY, Chou YC, Ke MJ, Li TY, Huang GS, et al. Six-month efficacy of platelet-rich plasma for carpal tunnel syndrome: A prospective randomized, single-blind controlled trial. Sci Rep. 2017;7(1):94. Epub 2017/03/10. doi: 10.1038/s41598-017-00224-6. PubMed PMID: 28273894; PubMed Central PMCID: PMCPMC5427966.
64. Desouza C, Dubey R, Shetty V. Platelet-rich plasma in chronic Achilles tendinopathy. Eur J Orthop Surg Traumatol. 2023;33(8):3255-65. Epub 2023/05/25. doi: 10.1007/s00590-023-03570-6. PubMed PMID: 37225947.
65. Silbernagel KG, Hanlon S, Sprague A. Current Clinical Concepts: Conservative Management of Achilles Tendinopathy. J Athl Train. 2020;55(5):438-47. Epub 2020/04/09. doi: 10.4085/1062-6050-356-19. PubMed PMID: 32267723; PubMed Central PMCID: PMCPMC7249277.
66. Abate M, Di Carlo L, Salini V. To evaluate the outcomes of PRP treatment in Achilles tendinopathy: An intriguing methodological problem. Orthop Traumatol Surg Res. 2021;107(6):102787. Epub 2020/12/18. doi: 10.1016/j.otsr.2020.102787. PubMed PMID: 33333266.
67. Gaweda K, Tarczynska M, Krzyzanowski W. Treatment of Achilles tendinopathy with platelet-rich plasma. Int J Sports Med. 2010;31(8):577-83. Epub 2010/06/11. doi: 10.1055/s-0030-1255028. PubMed PMID: 20535661.
68. Filardo G, Kon E, Di Matteo B, Di Martino A, Tesei G, Pelotti P, et al. Platelet-rich plasma injections for the treatment of refractory Achilles tendinopathy: results at 4 years. Blood Transfusion. 2014;12(4):533. doi: 10.2450/2014.0289-13. PubMed Central PMCID: PMC24960641.
69. Iacono V, Natali S, De Berardinis L, Screpis D, Gigante AP, Zorzi C. Return to Sports and Functional Outcomes after Autologous Platelet-Rich Fibrin Matrix (PRFM) and Debridement in Midportion Achilles Tendinopathy: A Case Series with 24-Month Follow-Up. J Clin Med. 2023;12(7):2747. Epub 2023/04/14. doi: 10.3390/jcm12072747. PubMed PMID: 37048830; PubMed Central PMCID: PMCPMC10094924.
70. Civitarese D, Downing MA, Bazzi MO, Flanagan G, Rothenberg JB. Platelet-rich Plasma Injection for the Treatment of Partial Achilles Tendon Rupture: A Case Report. Medical Research Archives. 2024;12(1). doi: 10.18103/mra.v12i1.4973.
71. Karjalainen TV, Silagy M, O'Bryan E, Johnston RV, Cyril S, Buchbinder R. Autologous blood and platelet-rich plasma injection therapy for lateral elbow pain. Cochrane Database Syst Rev. 2021;9(9):CD010951. Epub 2021/10/01. doi: 10.1002/14651858.CD010951.pub2. PubMed PMID: 34590307; PubMed Central PMCID: PMCPMC8481072.
72. Yanai K, Tajika T, Arisawa S, Hatori Y, Honda A, Hasegawa S, et al. Prevalence and factors associated with lateral epicondylitis among hospital healthcare workers. JSES Int. 2024;8(3):582-7. Epub 2024/05/06. doi: 10.1016/j.jseint.2024.01.008. PubMed PMID: 38707555; PubMed Central PMCID: PMCPMC11064715.
73. Karabinov V, Georgiev GP. Lateral epicondylitis: New trends and challenges in treatment. World J Orthop. 2022;13(4):354-64. Epub 2022/05/19. doi: 10.5312/wjo.v13.i4.354. PubMed PMID: 35582153; PubMed Central PMCID: PMCPMC9048498.
74. Mishra A, Pavelko T. Treatment of chronic elbow tendinosis with buffered platelet-rich plasma. Am J Sports Med. 2006;34(11):1774-8. Epub 2006/06/01. doi: 10.1177/0363546506288850. PubMed PMID: 16735582.
75. Fearon AM, Grimaldi A, Mellor R, Nasser AM, Fitzpatrick J, Ladurner A, et al. ICON 2020—International Scientific Tendinopathy Symposium Consensus: the development of a core outcome set for gluteal tendinopathy. British journal of sports medicine. 2024;58(5):245-54. doi: 10.1136/bjsports-2023-107150. PubMed Central PMCID: PMC38216320.
76. da Silva RT, Heidrich F. Therapy with use of platelet-rich plasma in orthopedics and sports traumatology: Literature review, evidence and personal experience. Platelet-Rich Plasma: Regenerative Medicine: Sports Medicine, Orthopedic, and Recovery of Musculoskeletal Injuries. 2013:153-70. doi: 10.1007/978-3-642-40117-6_6.
77. Peerbooms JC, Sluimer J, Bruijn DJ, Gosens T. Positive effect of an autologous platelet concentrate in lateral epicondylitis in a double-blind randomized controlled trial: platelet-rich plasma versus corticosteroid injection with a 1-year follow-up. Am J Sports Med. 2010;38(2):255-62. Epub 2010/05/08. doi: 10.1177/0363546509355445. PubMed PMID: 20448192.
78. Kim CH, Park YB, Lee JS, Jung HS. Platelet-rich plasma injection vs. operative treatment for lateral elbow tendinosis: a systematic review and meta-analysis. J Shoulder Elbow Surg. 2022;31(2):428-36. Epub 2021/10/18. doi: 10.1016/j.jse.2021.09.008. PubMed PMID: 34656779.
79. Andia I, Sánchez M, Maffulli N. Platelet rich plasma therapies for sports muscle injuries: any evidence behind clinical practice? Expert opinion on biological therapy. 2011;11(4):509-18. doi: 10.1517/14712598.2011.554813.
80. Hollabaugh WL, Sin A, Walden RL, Weaver JS, Porras LP, LeClere LE, et al. Outcomes of Activity-Related Lower Extremity Muscle Tears After Application of the British Athletics Muscle Injury Classification: A Systematic Review. Sports Health. 2024;16(5):783-96. Epub 2023/09/08. doi: 10.1177/19417381231195529. PubMed PMID: 37681683; PubMed Central PMCID: PMCPMC11346221.
81. Hammond JW, Hinton RY, Curl LA, Muriel JM, Lovering RM. Use of autologous platelet-rich plasma to treat muscle strain injuries. Am J Sports Med. 2009;37(6):1135-42. Epub 2009/03/14. doi: 10.1177/0363546508330974. PubMed PMID: 19282509; PubMed Central PMCID: PMCPMC3523111.
82. Bigham‐Sadegh A, Oryan A. Basic concepts regarding fracture healing and the current options and future directions in managing bone fractures. International wound journal. 2015;12(3):238-47. doi: 10.1111/iwj.12231. PubMed Central PMCID: PMC24618334.
83. Gan W, Xu Z, Wu C, He J. Effectiveness of platelet-rich plasma in the treatment of anterior cruciate ligament injuries: A Systematic Review and Meta-analysis. 2021. doi: 10.21203/rs.3.rs-1074595/v1.
84. Wright-Carpenter T, Klein P, Schaferhoff P, Appell HJ, Mir LM, Wehling P. Treatment of muscle injuries by local administration of autologous conditioned serum: a pilot study on sportsmen with muscle strains. Int J Sports Med. 2004;25(8):588-93. Epub 2004/11/09. doi: 10.1055/s-2004-821304. PubMed PMID: 15532001.
85. Antuña S, Barco R, Martinez Diez JM, Sanchez Marquez JM. Platelet-rich fibrin in arthroscopic repair of massive rotator cuff tears: a prospective randomized pilot clinical trial. Acta Orthop Belg. 2013;79(1):25-30. PubMed Central PMCID: PMC23547511.
86. Andrews JR, Elbayar JH, Jordan SE. Partial-rotator cuff tears in throwing athletes. Operative Techniques in Sports Medicine. 2021;29(1):150799. doi: 10.1016/j.otsm.2021.150799.
87. Vascellari A, Demeco A, Vittadini F, Gnasso R, Tarantino D, Belviso I, et al. Orthobiologics Injection Therapies in the Treatment of Muscle and Tendon Disorders in Athletes: Fact or Fake? Muscles, Ligaments & Tendons Journal (MLTJ). 2024;14(2). doi: 10.32098/mltj.02.2024.02.
88. Blaga FN, Nutiu AS, Lupsa AO, Ghiurau NA, Vlad SV, Ghitea TC. Exploring Platelet-Rich Plasma Therapy for Knee Osteoarthritis: An In-Depth Analysis. J Funct Biomater. 2024;15(8):221. Epub 2024/08/28. doi: 10.3390/jfb15080221. PubMed PMID: 39194659; PubMed Central PMCID: PMCPMC11355339.
89. Syed AN, Landrum K, Ganley TJ. Platelet-rich plasma and other injectables in the young athlete. Journal of the Pediatric Orthopaedic Society of North America. 2024;6:100008. doi: 10.1016/j.jposna.2024.100008.
90. Gharpinde MR, Pundkar A, Shrivastava S, Patel H, Chandanwale R. A Comprehensive Review of Platelet-Rich Plasma and Its Emerging Role in Accelerating Bone Healing. Cureus. 2024;16(2):e54122. Epub 2024/03/15. doi: 10.7759/cureus.54122. PubMed PMID: 38487114; PubMed Central PMCID: PMCPMC10939108.
91. Everts PA, van Erp A, DeSimone A, Cohen DS, Gardner RD. Platelet Rich Plasma in Orthopedic Surgical Medicine. Platelets. 2021;32(2):163-74. Epub 2021/01/06. doi: 10.1080/09537104.2020.1869717. PubMed PMID: 33400591.
92. Kuffler DP. Variables affecting the potential efficacy of PRP in providing chronic pain relief. J Pain Res. 2019;12:109-16. Epub 2019/01/08. doi: 10.2147/JPR.S190065. PubMed PMID: 30613159; PubMed Central PMCID: PMCPMC6306069.
93. Janocha A, Jerzak A, Hitnarowicz A, Kmak B, Szot A, Pociecha A. Platelet-rich plasma as a new treatment method in orthopedics. Journal of Education, Health and Sport. 2024;67:49195-. doi: 10.12775/JEHS.2024.67.49195.
94. McCarrel TM, Mall NA, Lee AS, Cole BJ, Butty DC, Fortier LA. Considerations for the use of platelet-rich plasma in orthopedics. Sports Med. 2014;44(8):1025-36. Epub 2014/04/25. doi: 10.1007/s40279-014-0195-5. PubMed PMID: 24760591.
95. De Macedo AP, Lana JFSD, Pedrozo CM, Bottene IC, De Medeiros JRM, Da Silva LQ. The regenerative medicine potential of PRP in elite athlete injuries. Fortune Journal of Rheumatology. 2020;2(1):16-26. doi: 10.1016/j.jorep.2023.100287.
96. Cao Y, Zhu X, Zhou R, He Y, Wu Z, Chen Y. A narrative review of the research progress and clinical application of platelet-rich plasma. Ann Palliat Med. 2021;10(4):4823-9. Epub 2021/03/12. doi: 10.21037/apm-20-2223. PubMed PMID: 33691459.
1. Mishra A, Harmon K, Woodall J, Vieira A. Sports medicine applications of platelet rich plasma. Curr Pharm Biotechnol. 2012;13(7):1185-95. Epub 2011/07/12. doi: 10.2174/138920112800624283. PubMed PMID: 21740373.
2. Tarmast D. The Critical Role of Nutrition in Acceleration of the Rehabilitation Process in Athletes. Journal of Physiology of Training and Sports Injuries. 2024;2(1):29-39.
3. Raum G, Kenyon C, Bowers R. Platelet-Poor versus Platelet-Rich Plasma for the Treatment of Muscle Injuries. Curr Sports Med Rep. 2024;23(6):222-8. Epub 2024/06/06. doi: 10.1249/JSR.0000000000001173. PubMed PMID: 38838685.
4. Sourugeon Y, Yonai Y, Berkovich Y, Laver L. Platelet-Rich Plasma Treatment for Muscle Injuries. Musculoskeletal Injections Manual: Basics, Techniques and Injectable Agents. 2024:99-104. doi: 10.1007/978-3-031-52603-9_17.
5. Paichitrojjana A, Paichitrojjana A. Platelet rich plasma and its use in hair regrowth: a review. Drug Design, Development and Therapy. 2023:635-45. doi: 10.2147/DDDT.S356858. PubMed Central PMCID: PMC35300222.
6. Zaki SN, Mardyansyah, Oktarina C, Purwoko RY, Sutanto HU. Platelet-Rich Plasma for the Treatment of Atopic Dermatitis: A Literature Review. J Clin Aesthet Dermatol. 2024;17(7):43-9. Epub 2024/07/15. PubMed PMID: 39006806; PubMed Central PMCID: PMCPMC11238712.
7. Xu J, Gou L, Zhang P, Li H, Qiu S. Platelet-rich plasma and regenerative dentistry. Aust Dent J. 2020;65(2):131-42. Epub 2020/03/08. doi: 10.1111/adj.12754. PubMed PMID: 32145082; PubMed Central PMCID: PMCPMC7384010.
8. Kon E, Filardo G, Di Martino A, Marcacci M. Platelet-rich plasma (PRP) to treat sports injuries: evidence to support its use. Knee Surg Sports Traumatol Arthrosc. 2011;19(4):516-27. Epub 2010/11/18. doi: 10.1007/s00167-010-1306-y. PubMed PMID: 21082164.
9. Marques LF, Stessuk T, Camargo IC, Sabeh Junior N, dos Santos L, Ribeiro-Paes JT. Platelet-rich plasma (PRP): methodological aspects and clinical applications. Platelets. 2015;26(2):101-13. Epub 2014/02/12. doi: 10.3109/09537104.2014.881991. PubMed PMID: 24512369.
10. Tarmast D, Ghosh AK. The Impact of Carbohydrate, Protein, and Combined Carbohydrate-Protein Supplementation on Muscle Damage and Oxidative Stress Markers During Prolonged Cycling Performance in the Heat. Asian Journal of Sports Medicine. 2024;15(2):e144084. Epub 2024-08-01. doi: 10.5812/asjsm-144084.
11. Zhu T, Zhou J, Hwang J, Xu X. Effects of Platelet-Rich Plasma on Clinical Outcomes After Anterior Cruciate Ligament Reconstruction: A Systematic Review and Meta-analysis. Orthop J Sports Med. 2022;10(1):23259671211061535. Epub 2022/02/08. doi: 10.1177/23259671211061535. PubMed PMID: 35127959; PubMed Central PMCID: PMCPMC8811441.
12. Flury M, Rickenbacher D, Schwyzer H-K, Jung C, Schneider MM, Stahnke K, et al. Does pure platelet-rich plasma affect postoperative clinical outcomes after arthroscopic rotator cuff repair? A randomized controlled trial. The American journal of sports medicine. 2016;44(8):2136-46. doi: 10.1177/0363546516645518. PubMed Central PMCID: PMC27184542.
13. Manso BA, Rodriguez YBA, Forsberg EC. From Hematopoietic Stem Cells to Platelets: Unifying Differentiation Pathways Identified by Lineage Tracing Mouse Models. Cells. 2024;13(8):704. Epub 2024/04/26. doi: 10.3390/cells13080704. PubMed PMID: 38667319; PubMed Central PMCID: PMCPMC11048769.
14. Malara A, Abbonante V, Zingariello M, Migliaccio A, Balduini A. Megakaryocyte Contribution to Bone Marrow Fibrosis: many Arrows in the Quiver. Mediterr J Hematol Infect Dis. 2018;10(1):e2018068. Epub 2018/11/13. doi: 10.4084/MJHID.2018.068. PubMed PMID: 30416700; PubMed Central PMCID: PMCPMC6223581.
15. Psaila B, Lyden D, Roberts I. Megakaryocytes, malignancy and bone marrow vascular niches. J Thromb Haemost. 2012;10(2):177-88. Epub 2011/11/30. doi: 10.1111/j.1538-7836.2011.04571.x. PubMed PMID: 22122829; PubMed Central PMCID: PMCPMC3272087.
16. Bates DO, Beazley-Long N, Benest AV, Ye X, Ved N, Hulse RP, et al. Physiological role of vascular endothelial growth factors as homeostatic regulators. Comprehensive Physiology. 2018;8(3). doi: 10.1002/cphy.c170015. PubMed Central PMCID: PMC29978898.
17. Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M. Growth factors and cytokines in wound healing. Wound Repair Regen. 2008;16(5):585-601. Epub 2009/01/09. doi: 10.1111/j.1524-475X.2008.00410.x. PubMed PMID: 19128254.
18. Wee P, Wang Z. Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways. Cancers (Basel). 2017;9(5):52. Epub 2017/05/18. doi: 10.3390/cancers9050052. PubMed PMID: 28513565; PubMed Central PMCID: PMCPMC5447962.
19. Farooq M, Khan AW, Kim MS, Choi S. The Role of Fibroblast Growth Factor (FGF) Signaling in Tissue Repair and Regeneration. Cells. 2021;10(11):3242. Epub 2021/11/28. doi: 10.3390/cells10113242. PubMed PMID: 34831463; PubMed Central PMCID: PMCPMC8622657.
20. Creaney L, Hamilton B. Growth factor delivery methods in the management of sports injuries: the state of play. Br J Sports Med. 2008;42(5):314-20. Epub 2007/11/07. doi: 10.1136/bjsm.2007.040071. PubMed PMID: 17984193.
21. Andia I, Martin JI, Maffulli N. Advances with platelet rich plasma therapies for tendon regeneration. Expert Opin Biol Ther. 2018;18(4):389-98. Epub 2018/01/05. doi: 10.1080/14712598.2018.1424626. PubMed PMID: 29300106.
22. Andia I, Maffulli N. Muscle and tendon injuries: the role of biological interventions to promote and assist healing and recovery. Arthroscopy. 2015;31(5):999-1015. Epub 2015/01/27. doi: 10.1016/j.arthro.2014.11.024. PubMed PMID: 25618490.
23. Maffulli N, Longo UG, Kadakia A, Spiezia F. Achilles tendinopathy. Foot and Ankle Surgery. 2020;26(3):240-9. doi: 10.1016/j.fas.2019.03.009. PubMed Central PMCID: PMC31031150.
24. Patil P, Jadhav M, Suvvari TK, Thomas V. Therapeutic uses of platelet-rich plasma (PRP) in sport injuries–A narrative review. Journal of Orthopaedic Reports. 2023:100287. doi: 10.1016/j.jorep.2023.100287.
25. Yuan T, Zhang CQ, Wang JH. Augmenting tendon and ligament repair with platelet-rich plasma (PRP). Muscles Ligaments Tendons J. 2013;3(3):139-49. Epub 2013/12/25. PubMed PMID: 24367773; PubMed Central PMCID: PMCPMC3838322.
26. Laver L, Solis GS, Gilat R, García-Balletbó M, Lopez-Vidriero E, Cole B, et al. The Role of Orthobiologics for the Management of Ligament and Muscle Injuries in Sports. In: Laver L, Kocaoglu B, Cole B, Arundale AJH, Bytomski J, Amendola A, editors. Basketball Sports Medicine and Science. Berlin, Heidelberg: Springer Berlin Heidelberg; 2020. p. 587-603.
27. Barastegui D, Alentorn-Geli E, Gotecha D, Rius M, Navarro J, Cusco X, et al. Treatment of Partial Posterior Cruciate Ligament Injuries with Platelet-Rich Plasma in Growth Factors (PRGF) Intraligamentous Infiltration and a Specific Knee Brace. Surg J (N Y). 2021;7(1):e30-e4. Epub 2021/03/05. doi: 10.1055/s-0040-1722342. PubMed PMID: 33659640; PubMed Central PMCID: PMCPMC7917000.
28. Jordan M, Spörri J, Taylor J. Injury Prevention and Rehabilitation. In: Pritchard J, Taylor J, editors. The Science of Alpine Ski Racing: Routledge; 2022. p. 113-53.
29. Heiderscheit BC, Sherry MA, Silder A, Chumanov ES, Thelen DG. Hamstring strain injuries: recommendations for diagnosis, rehabilitation, and injury prevention. J Orthop Sports Phys Ther. 2010;40(2):67-81. Epub 2010/02/02. doi: 10.2519/jospt.2010.3047. PubMed PMID: 20118524; PubMed Central PMCID: PMCPMC2867336.
30. Herdea A, Struta A, Derihaci RP, Ulici A, Costache A, Furtunescu F, et al. Efficiency of platelet-rich plasma therapy for healing sports injuries in young athletes. Exp Ther Med. 2022;23(3):215. Epub 2022/02/08. doi: 10.3892/etm.2022.11139. PubMed PMID: 35126718; PubMed Central PMCID: PMCPMC8796279.
31. Nguyen RT, Borg-Stein J, McInnis K. Applications of platelet-rich plasma in musculoskeletal and sports medicine: an evidence-based approach. PM R. 2011;3(3):226-50. Epub 2011/03/16. doi: 10.1016/j.pmrj.2010.11.007. PubMed PMID: 21402369.
32. Weibrich G, Kleis WK, Hafner G. Growth factor levels in the platelet-rich plasma produced by 2 different methods: curasan-type PRP kit versus PCCS PRP system. Int J Oral Maxillofac Implants. 2002;17(2):184-90. Epub 2002/04/18. PubMed PMID: 11958400; PubMed Central PMCID: PMC11958400.
33. Marx RE. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg. 2004;62(4):489-96. Epub 2004/04/16. doi: 10.1016/j.joms.2003.12.003. PubMed PMID: 15085519.
34. Bava ED, Barber FA. Platelet-rich plasma products in sports medicine. Phys Sportsmed. 2011;39(3):94-9. Epub 2011/10/28. doi: 10.3810/psm.2011.09.1925. PubMed PMID: 22030945.
35. Yu H, Habibi M, Motamedi K, Semirumi DT, Ghorbani A. Utilizing stem cells in reconstructive treatments for sports injuries: An innovative approach. Tissue Cell. 2023;83:102152. Epub 2023/07/15. doi: 10.1016/j.tice.2023.102152. PubMed PMID: 37451009.
36. Boivin J, Tolsma R, Awad P, Kenter K, Li Y. The Biological Use of Platelet-Rich Plasma in Skeletal Muscle Injury and Repair. Am J Sports Med. 2023;51(5):1347-55. Epub 2021/12/15. doi: 10.1177/03635465211061606. PubMed PMID: 34904902.
37. Andia I, Sanchez M, Maffulli N. Tendon healing and platelet-rich plasma therapies. Expert Opin Biol Ther. 2010;10(10):1415-26. Epub 2010/08/20. doi: 10.1517/14712598.2010.514603. PubMed PMID: 20718690.
38. Padilla S, Sánchez M, Vaquerizo V, Malanga GA, Fiz N, Azofra J, et al. Platelet-rich plasma applications for Achilles tendon repair: a bridge between biology and surgery. International journal of molecular sciences. 2021;22(2):824. doi: 10.3390/ijms22020824. PubMed Central PMCID: PMC33467646.
39. Le ADK, Enweze L, DeBaun MR, Dragoo JL. Current Clinical Recommendations for Use of Platelet-Rich Plasma. Curr Rev Musculoskelet Med. 2018;11(4):624-34. Epub 2018/10/26. doi: 10.1007/s12178-018-9527-7. PubMed PMID: 30353479; PubMed Central PMCID: PMCPMC6220007.
40. Laver L, Carmont MR, McConkey MO, Palmanovich E, Yaacobi E, Mann G, et al. Plasma rich in growth factors (PRGF) as a treatment for high ankle sprain in elite athletes: a randomized control trial. Knee Surgery, Sports Traumatology, Arthroscopy. 2015;23:3383-92. doi: 10.1007/s00167-014-3119-x. PubMed Central PMCID: PMC24938396.
41. Cavallo C, Roffi A, Grigolo B, Mariani E, Pratelli L, Merli G, et al. Platelet-Rich Plasma: The Choice of Activation Method Affects the Release of Bioactive Molecules. Biomed Res Int. 2016;2016(1):6591717. Epub 2016/09/28. doi: 10.1155/2016/6591717. PubMed PMID: 27672658; PubMed Central PMCID: PMCPMC5031826.
42. Patel H, Pundkar A, Shrivastava S, Chandanwale R, Jaiswal AM. A Comprehensive Review on Platelet-Rich Plasma Activation: A Key Player in Accelerating Skin Wound Healing. Cureus. 2023;15(11):e48943. Epub 2023/12/18. doi: 10.7759/cureus.48943. PubMed PMID: 38106716; PubMed Central PMCID: PMCPMC10725573.
43. Asker M, Whiteley R. Rehabilitation and Return to Sports After Shoulder Injuries. Orthopaedic Sports Medicine: An Encyclopedic Review of Diagnosis, Prevention, and Management: Springer; 2024. p. 1-23.
44. Murrell WD, Tulpule S, Yurdi NA, Ezekwesili A, Maffulli N, Malanga GA. Orthobiologics for the Treatment of Tennis Elbow. Orthobiologics: Injectable Therapies for the Musculoskeletal System. 2022:191-204. doi: 10.1007/978-3-030-84744-9_15.
45. Wong JRY, Toth E, Rajesparan K, Rashid A. The use of platelet-rich plasma therapy in treating tennis elbow: A critical review of randomised control trials. J Clin Orthop Trauma. 2022;32:101965. Epub 2022/08/23. doi: 10.1016/j.jcot.2022.101965. PubMed PMID: 35990997; PubMed Central PMCID: PMCPMC9382321.
46. Miller TL, Kaeding CC, Rodeo SA. Emerging Options for Biologic Enhancement of Stress Fracture Healing in Athletes. J Am Acad Orthop Surg. 2020;28(1):1-9. Epub 2019/07/25. doi: 10.5435/JAAOS-D-19-00112. PubMed PMID: 31335452.
47. Sanders TL, Maradit Kremers H, Bryan AJ, Larson DR, Dahm DL, Levy BA, et al. Incidence of Anterior Cruciate Ligament Tears and Reconstruction: A 21-Year Population-Based Study. Am J Sports Med. 2016;44(6):1502-7. Epub 2016/02/28. doi: 10.1177/0363546516629944. PubMed PMID: 26920430.
48. Nessler T, Denney L, Sampley J. ACL injury prevention: what does research tell us? Current reviews in musculoskeletal medicine. 2017;10:281-8. doi: 10.1007/s12178-017-9416-5. PubMed Central PMCID: PMC28656531.
49. Thomas AC, Villwock M, Wojtys EM, Palmieri-Smith RM. Lower extremity muscle strength after anterior cruciate ligament injury and reconstruction. Journal of athletic training. 2013;48(5):610-20. doi: 10.4085/1062-6050-48.3.23. PubMed Central PMCID: PMC24067150.
50. Fleming BC, Spindler KP, Palmer MP, Magarian EM, Murray MM. Collagen-platelet composites improve the biomechanical properties of healing anterior cruciate ligament grafts in a porcine model. Am J Sports Med. 2009;37(8):1554-63. Epub 2009/04/02. doi: 10.1177/0363546509332257. PubMed PMID: 19336614; PubMed Central PMCID: PMCPMC2796133.
51. Radice F, Yánez R, Gutiérrez V, Rosales J, Pinedo M, Coda S. Comparison of magnetic resonance imaging findings in anterior cruciate ligament grafts with and without autologous platelet-derived growth factors. Arthroscopy: The Journal of Arthroscopic & Related Surgery. 2010;26(1):50-7. doi: 10.1016/j.arthro.2009.06.030. PubMed Central PMCID: PMC20117627.
52. López-Vidriero E, Olivé-Vilas R, López-Capapé D, Varela-Sende L, López-Vidriero R, Til-Pérez L. Efficacy and tolerability of progen, a nutritional supplement based on innovative plasma proteins, in ACL reconstruction: A multicenter randomized controlled trial. Orthopaedic Journal of Sports Medicine. 2019;7(2):2325967119827237. doi: 10.1177/2325967119827237. PubMed Central PMCID: PMC30834280.
53. Cervellin M, de Girolamo L, Bait C, Denti M, Volpi P. Autologous platelet-rich plasma gel to reduce donor-site morbidity after patellar tendon graft harvesting for anterior cruciate ligament reconstruction: a randomized, controlled clinical study. Knee Surg Sports Traumatol Arthrosc. 2012;20(1):114-20. Epub 2011/06/17. doi: 10.1007/s00167-011-1570-5. PubMed PMID: 21678095.
54. Rupreht M, Jevtic V, Sersa I, Vogrin M, Jevsek M. Evaluation of the tibial tunnel after intraoperatively administered platelet-rich plasma gel during anterior cruciate ligament reconstruction using diffusion weighted and dynamic contrast-enhanced MRI. J Magn Reson Imaging. 2013;37(4):928-35. Epub 2012/10/26. doi: 10.1002/jmri.23886. PubMed PMID: 23097413.
55. Vogrin M, Rupreht M, Dinevski D, Haspl M, Kuhta M, Jevsek M, et al. Effects of a platelet gel on early graft revascularization after anterior cruciate ligament reconstruction: a prospective, randomized, double-blind, clinical trial. Eur Surg Res. 2010;45(2):77-85. Epub 2010/09/04. doi: 10.1159/000318597. PubMed PMID: 20814217.
56. Seijas R, Ares O, Catala J, Alvarez-Diaz P, Cusco X, Cugat R. Magnetic resonance imaging evaluation of patellar tendon graft remodelling after anterior cruciate ligament reconstruction with or without platelet-rich plasma. Journal of Orthopaedic Surgery. 2013;21(1):10-4. doi: 10.1177/230949901302100105. PubMed Central PMCID: PMC23629979.
57. Chen W, Cloosterman KLA, Bierma-Zeinstra SMA, van Middelkoop M, de Vos RJ. Epidemiology of insertional and midportion Achilles tendinopathy in runners: A prospective cohort study. J Sport Health Sci. 2024;13(2):256-63. Epub 2023/03/25. doi: 10.1016/j.jshs.2023.03.007. PubMed PMID: 36963760; PubMed Central PMCID: PMCPMC10980873.
58. Fares MY, Khachfe HH, Salhab HA, Zbib J, Fares Y, Fares J. Achilles tendinopathy: Exploring injury characteristics and current treatment modalities. Foot (Edinb). 2021;46:101715. Epub 2020/10/12. doi: 10.1016/j.foot.2020.101715. PubMed PMID: 33039245.
59. Arthur Vithran DT, Xie W, Opoku M, Essien AE, He M, Li Y. The Efficacy of Platelet-Rich Plasma Injection Therapy in the Treatment of Patients with Achilles Tendinopathy: A Systematic Review and Meta-Analysis. J Clin Med. 2023;12(3):995. Epub 2023/02/12. doi: 10.3390/jcm12030995. PubMed PMID: 36769643; PubMed Central PMCID: PMCPMC9918262.
60. Weller CD, Gardiner EE, Arthur JF, Southey M, Andrews RK. Autologous platelet-rich plasma for healing chronic venous leg ulcers: Clinical efficacy and potential mechanisms. Int Wound J. 2019;16(3):788-92. Epub 2019/03/14. doi: 10.1111/iwj.13098. PubMed PMID: 30864220; PubMed Central PMCID: PMCPMC7949463.
61. Gentile P, Calabrese C, De Angelis B, Dionisi L, Pizzicannella J, Kothari A, et al. Impact of the Different Preparation Methods to Obtain Autologous Non-Activated Platelet-Rich Plasma (A-PRP) and Activated Platelet-Rich Plasma (AA-PRP) in Plastic Surgery: Wound Healing and Hair Regrowth Evaluation. Int J Mol Sci. 2020;21(2):431. Epub 2020/01/16. doi: 10.3390/ijms21020431. PubMed PMID: 31936605; PubMed Central PMCID: PMCPMC7014364.
62. Uzun H, Bitik O, Uzun O, Ersoy US, Aktas E. Platelet-rich plasma versus corticosteroid injections for carpal tunnel syndrome. J Plast Surg Hand Surg. 2017;51(5):301-5. Epub 2016/12/07. doi: 10.1080/2000656X.2016.1260025. PubMed PMID: 27921443.
63. Wu YT, Ho TY, Chou YC, Ke MJ, Li TY, Huang GS, et al. Six-month efficacy of platelet-rich plasma for carpal tunnel syndrome: A prospective randomized, single-blind controlled trial. Sci Rep. 2017;7(1):94. Epub 2017/03/10. doi: 10.1038/s41598-017-00224-6. PubMed PMID: 28273894; PubMed Central PMCID: PMCPMC5427966.
64. Desouza C, Dubey R, Shetty V. Platelet-rich plasma in chronic Achilles tendinopathy. Eur J Orthop Surg Traumatol. 2023;33(8):3255-65. Epub 2023/05/25. doi: 10.1007/s00590-023-03570-6. PubMed PMID: 37225947.
65. Silbernagel KG, Hanlon S, Sprague A. Current Clinical Concepts: Conservative Management of Achilles Tendinopathy. J Athl Train. 2020;55(5):438-47. Epub 2020/04/09. doi: 10.4085/1062-6050-356-19. PubMed PMID: 32267723; PubMed Central PMCID: PMCPMC7249277.
66. Abate M, Di Carlo L, Salini V. To evaluate the outcomes of PRP treatment in Achilles tendinopathy: An intriguing methodological problem. Orthop Traumatol Surg Res. 2021;107(6):102787. Epub 2020/12/18. doi: 10.1016/j.otsr.2020.102787. PubMed PMID: 33333266.
67. Gaweda K, Tarczynska M, Krzyzanowski W. Treatment of Achilles tendinopathy with platelet-rich plasma. Int J Sports Med. 2010;31(8):577-83. Epub 2010/06/11. doi: 10.1055/s-0030-1255028. PubMed PMID: 20535661.
68. Filardo G, Kon E, Di Matteo B, Di Martino A, Tesei G, Pelotti P, et al. Platelet-rich plasma injections for the treatment of refractory Achilles tendinopathy: results at 4 years. Blood Transfusion. 2014;12(4):533. doi: 10.2450/2014.0289-13. PubMed Central PMCID: PMC24960641.
69. Iacono V, Natali S, De Berardinis L, Screpis D, Gigante AP, Zorzi C. Return to Sports and Functional Outcomes after Autologous Platelet-Rich Fibrin Matrix (PRFM) and Debridement in Midportion Achilles Tendinopathy: A Case Series with 24-Month Follow-Up. J Clin Med. 2023;12(7):2747. Epub 2023/04/14. doi: 10.3390/jcm12072747. PubMed PMID: 37048830; PubMed Central PMCID: PMCPMC10094924.
70. Civitarese D, Downing MA, Bazzi MO, Flanagan G, Rothenberg JB. Platelet-rich Plasma Injection for the Treatment of Partial Achilles Tendon Rupture: A Case Report. Medical Research Archives. 2024;12(1). doi: 10.18103/mra.v12i1.4973.
71. Karjalainen TV, Silagy M, O'Bryan E, Johnston RV, Cyril S, Buchbinder R. Autologous blood and platelet-rich plasma injection therapy for lateral elbow pain. Cochrane Database Syst Rev. 2021;9(9):CD010951. Epub 2021/10/01. doi: 10.1002/14651858.CD010951.pub2. PubMed PMID: 34590307; PubMed Central PMCID: PMCPMC8481072.
72. Yanai K, Tajika T, Arisawa S, Hatori Y, Honda A, Hasegawa S, et al. Prevalence and factors associated with lateral epicondylitis among hospital healthcare workers. JSES Int. 2024;8(3):582-7. Epub 2024/05/06. doi: 10.1016/j.jseint.2024.01.008. PubMed PMID: 38707555; PubMed Central PMCID: PMCPMC11064715.
73. Karabinov V, Georgiev GP. Lateral epicondylitis: New trends and challenges in treatment. World J Orthop. 2022;13(4):354-64. Epub 2022/05/19. doi: 10.5312/wjo.v13.i4.354. PubMed PMID: 35582153; PubMed Central PMCID: PMCPMC9048498.
74. Mishra A, Pavelko T. Treatment of chronic elbow tendinosis with buffered platelet-rich plasma. Am J Sports Med. 2006;34(11):1774-8. Epub 2006/06/01. doi: 10.1177/0363546506288850. PubMed PMID: 16735582.
75. Fearon AM, Grimaldi A, Mellor R, Nasser AM, Fitzpatrick J, Ladurner A, et al. ICON 2020—International Scientific Tendinopathy Symposium Consensus: the development of a core outcome set for gluteal tendinopathy. British journal of sports medicine. 2024;58(5):245-54. doi: 10.1136/bjsports-2023-107150. PubMed Central PMCID: PMC38216320.
76. da Silva RT, Heidrich F. Therapy with use of platelet-rich plasma in orthopedics and sports traumatology: Literature review, evidence and personal experience. Platelet-Rich Plasma: Regenerative Medicine: Sports Medicine, Orthopedic, and Recovery of Musculoskeletal Injuries. 2013:153-70. doi: 10.1007/978-3-642-40117-6_6.
77. Peerbooms JC, Sluimer J, Bruijn DJ, Gosens T. Positive effect of an autologous platelet concentrate in lateral epicondylitis in a double-blind randomized controlled trial: platelet-rich plasma versus corticosteroid injection with a 1-year follow-up. Am J Sports Med. 2010;38(2):255-62. Epub 2010/05/08. doi: 10.1177/0363546509355445. PubMed PMID: 20448192.
78. Kim CH, Park YB, Lee JS, Jung HS. Platelet-rich plasma injection vs. operative treatment for lateral elbow tendinosis: a systematic review and meta-analysis. J Shoulder Elbow Surg. 2022;31(2):428-36. Epub 2021/10/18. doi: 10.1016/j.jse.2021.09.008. PubMed PMID: 34656779.
79. Andia I, Sánchez M, Maffulli N. Platelet rich plasma therapies for sports muscle injuries: any evidence behind clinical practice? Expert opinion on biological therapy. 2011;11(4):509-18. doi: 10.1517/14712598.2011.554813.
80. Hollabaugh WL, Sin A, Walden RL, Weaver JS, Porras LP, LeClere LE, et al. Outcomes of Activity-Related Lower Extremity Muscle Tears After Application of the British Athletics Muscle Injury Classification: A Systematic Review. Sports Health. 2024;16(5):783-96. Epub 2023/09/08. doi: 10.1177/19417381231195529. PubMed PMID: 37681683; PubMed Central PMCID: PMCPMC11346221.
81. Hammond JW, Hinton RY, Curl LA, Muriel JM, Lovering RM. Use of autologous platelet-rich plasma to treat muscle strain injuries. Am J Sports Med. 2009;37(6):1135-42. Epub 2009/03/14. doi: 10.1177/0363546508330974. PubMed PMID: 19282509; PubMed Central PMCID: PMCPMC3523111.
82. Bigham‐Sadegh A, Oryan A. Basic concepts regarding fracture healing and the current options and future directions in managing bone fractures. International wound journal. 2015;12(3):238-47. doi: 10.1111/iwj.12231. PubMed Central PMCID: PMC24618334.
83. Gan W, Xu Z, Wu C, He J. Effectiveness of platelet-rich plasma in the treatment of anterior cruciate ligament injuries: A Systematic Review and Meta-analysis. 2021. doi: 10.21203/rs.3.rs-1074595/v1.
84. Wright-Carpenter T, Klein P, Schaferhoff P, Appell HJ, Mir LM, Wehling P. Treatment of muscle injuries by local administration of autologous conditioned serum: a pilot study on sportsmen with muscle strains. Int J Sports Med. 2004;25(8):588-93. Epub 2004/11/09. doi: 10.1055/s-2004-821304. PubMed PMID: 15532001.
85. Antuña S, Barco R, Martinez Diez JM, Sanchez Marquez JM. Platelet-rich fibrin in arthroscopic repair of massive rotator cuff tears: a prospective randomized pilot clinical trial. Acta Orthop Belg. 2013;79(1):25-30. PubMed Central PMCID: PMC23547511.
86. Andrews JR, Elbayar JH, Jordan SE. Partial-rotator cuff tears in throwing athletes. Operative Techniques in Sports Medicine. 2021;29(1):150799. doi: 10.1016/j.otsm.2021.150799.
87. Vascellari A, Demeco A, Vittadini F, Gnasso R, Tarantino D, Belviso I, et al. Orthobiologics Injection Therapies in the Treatment of Muscle and Tendon Disorders in Athletes: Fact or Fake? Muscles, Ligaments & Tendons Journal (MLTJ). 2024;14(2). doi: 10.32098/mltj.02.2024.02.
88. Blaga FN, Nutiu AS, Lupsa AO, Ghiurau NA, Vlad SV, Ghitea TC. Exploring Platelet-Rich Plasma Therapy for Knee Osteoarthritis: An In-Depth Analysis. J Funct Biomater. 2024;15(8):221. Epub 2024/08/28. doi: 10.3390/jfb15080221. PubMed PMID: 39194659; PubMed Central PMCID: PMCPMC11355339.
89. Syed AN, Landrum K, Ganley TJ. Platelet-rich plasma and other injectables in the young athlete. Journal of the Pediatric Orthopaedic Society of North America. 2024;6:100008. doi: 10.1016/j.jposna.2024.100008.
90. Gharpinde MR, Pundkar A, Shrivastava S, Patel H, Chandanwale R. A Comprehensive Review of Platelet-Rich Plasma and Its Emerging Role in Accelerating Bone Healing. Cureus. 2024;16(2):e54122. Epub 2024/03/15. doi: 10.7759/cureus.54122. PubMed PMID: 38487114; PubMed Central PMCID: PMCPMC10939108.
91. Everts PA, van Erp A, DeSimone A, Cohen DS, Gardner RD. Platelet Rich Plasma in Orthopedic Surgical Medicine. Platelets. 2021;32(2):163-74. Epub 2021/01/06. doi: 10.1080/09537104.2020.1869717. PubMed PMID: 33400591.
92. Kuffler DP. Variables affecting the potential efficacy of PRP in providing chronic pain relief. J Pain Res. 2019;12:109-16. Epub 2019/01/08. doi: 10.2147/JPR.S190065. PubMed PMID: 30613159; PubMed Central PMCID: PMCPMC6306069.
93. Janocha A, Jerzak A, Hitnarowicz A, Kmak B, Szot A, Pociecha A. Platelet-rich plasma as a new treatment method in orthopedics. Journal of Education, Health and Sport. 2024;67:49195-. doi: 10.12775/JEHS.2024.67.49195.
94. McCarrel TM, Mall NA, Lee AS, Cole BJ, Butty DC, Fortier LA. Considerations for the use of platelet-rich plasma in orthopedics. Sports Med. 2014;44(8):1025-36. Epub 2014/04/25. doi: 10.1007/s40279-014-0195-5. PubMed PMID: 24760591.
95. De Macedo AP, Lana JFSD, Pedrozo CM, Bottene IC, De Medeiros JRM, Da Silva LQ. The regenerative medicine potential of PRP in elite athlete injuries. Fortune Journal of Rheumatology. 2020;2(1):16-26. doi: 10.1016/j.jorep.2023.100287.
96. Cao Y, Zhu X, Zhou R, He Y, Wu Z, Chen Y. A narrative review of the research progress and clinical application of platelet-rich plasma. Ann Palliat Med. 2021;10(4):4823-9. Epub 2021/03/12. doi: 10.21037/apm-20-2223. PubMed PMID: 33691459.
